Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification related to a Phase 2 study of Cabozantinib in Japanese participants with advanced hepatocellular carcinoma who have received prior systemic anticancer therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:57.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for Japanese individuals aged 20 or older with a histological or cytological diagnosis of HCC. The previous generic statement 'No information provided' has been replaced with specific inclusion and exclusion criteria for the study.
    Difference
    55%
    Check dated 2024-05-22T21:04:28.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:21:46.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.